|
|
Article: Renagel in New Dialysis Study Published in Kidney International.
- Article from:
- PR Newswire
- Article date:
- January 8, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Show That Patients Treated with Renagel Achieve Mortality Benefit
CAMBRIDGE, Mass., Jan. 8 /PRNewswire-FirstCall/ -- Genzyme Corporation announced today that findings published in the online version of Kidney International demonstrate that patients using Renagel experienced a significantly lower rate of death compared with patients using calcium-based phosphate binders in a newly completed study.
The results were drawn from the Renagel in New Dialysis study (RIND), a randomized open-label trial involving 127 patients new to hemodialysis at five dialysis centers in the United States. All-cause mortality was a pre-specified secondary endpoint. ...